Momo Gem Peregrine Pharmaceuticals (PPHM) Higher After Recent Consolidation
Tweet Send to a FriendGet Alerts PPHM Hot Sheet
Up)
Trade PPHM Now!
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) is seeing notable upside mid-day Tuesday. Shares are up 28 percent currently after consolidating over the past few following a negative SeekingAlpha article on Monday.
Shares of PPHM are up an astonishing 340 percent since the end of June, mainly on the hopes for cancer drug bavituximab. A recent Phase II study showed the doubling of tumor response rates, a 50% increase in median progression free survival, and trends toward significant improvement in median overall survival.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Shares of PPHM are up an astonishing 340 percent since the end of June, mainly on the hopes for cancer drug bavituximab. A recent Phase II study showed the doubling of tumor response rates, a 50% increase in median progression free survival, and trends toward significant improvement in median overall survival.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Tesla (TSLA) Ramps Higher (GM)
- StreetInsider.com Pre-Open Movers 6/17: (KNDI) (NFLX) (AMD) Higher; (FOLD) (TEX) (ARMH) Lower (more...)
- Mediabistro (MBIS) Surges, But No One Knows Why
Create E-mail Alert Related Categories
Momentum Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
